3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pain, Postoperative
31
Breast Neoplasms
24
Agnosia
11
Pain
10
Lung Neoplasms
10
Leiomyoma
7
Pancreatic Neoplasms
5
Neoplasms
5
Prostatic Neoplasms
4
Rectal Neoplasms
3
Neuroma
3
Neuralgia
3
Hot Flashes
3
Colorectal Neoplasms
3
Colonic Neoplasms
3
Thyroid Nodule
2
Thyroid Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphedema
2
Liver Neoplasms
2
Kidney Neoplasms
2
Ileus
2
Hyperparathyroidism
2
Goiter
2
Digestive System Diseases
2
Chronic Pain
2
Breast Cancer Female
2
Brain Neoplasms
2
Adenomyosis
2
Abdominal Cancer
2
Interventions
alvimopan
5
Irinotecan
4
Oxaliplatin
3
Capecitabine
3
Bevacizumab
3
Leucovorin
2
Fluorouracil
2
Cyclophosphamide
2
Cetuximab
2
Aspirin
2
repotrectinib
1
pralsetinib
1
pembrolizumab
1
napabucasin
1
guadecitabine
1
encorafenib
1
alectinib
1
Ursodeoxycholic Acid
1
Surveys and Questionnaires
1
Pemetrexed
1
Oviposition
1
Ocoxin
1
Levoleucovorin
1
KRN-330
1
Folfox protocol
1
Exercise
1
Drug Therapy
1
Drainage
1
Chemoradiotherapy
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Intestinal Diseases
×
Bupivacaine
×
Clear all
NCT03723447
2021-02-17
TINGLE
Cedars-Sinai Medical Center
Phase 4
Completed
102 enrolled
9 charts